Contractor
THE HARVARD DRUG GROUP, L.L.C.
- UEI
- CBGGKKVNJBK9
- Parent UEI
- N25KC4APTJ98
- Resolved by
- uei
- Confidence
- 1.000
Active from Jul 14, 2021 to Oct 6, 2026.
Sign in to watchRecent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 36F79725D0121 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD | Department of Veterans Affairs | — | Apr 28, 2025 | — |
| 36E79725D0010 NEW AWARD FOR BUPROPION TABLETS WITH MAJOR. PERIOD OF PERFORMANCE IS 3/1/2025-2/28/2026 WITH FOUR ONE-YEAR OPTIONS | Department of Veterans Affairs | — | Dec 31, 2024 | — |
| 36E79725D0001 NEW AWARD FOR LURASIDONE HCL TABLETS WITH THE HARVARD DRUG GROUP, L.L.C. DBA MAJOR PHARMACEUTICALS. BASE YEAR ORDERING PERIOD IS 12/10/2024 TO 12/09/2025 WITH FOUR ONE-YEAR OPTIONS. | Department of Veterans Affairs | — | Oct 10, 2024 | — |
| 36E79721D0048 VA DOD IHS BOP FHCC OPTION 2 STATE VETERANS HOMES | Department of Veterans Affairs | — | Jul 14, 2021 | — |
| 36E79721D0038 INCORPORATE ADDRESS CHANGE FOR NICOTINE CONTRACT | Department of Veterans Affairs | — | May 4, 2026 | — |
| SPE2D326F8750 4571306863!MUCUS RELIEF ER 600 MG TABLET 500S | Department of Defense | TN | Mar 27, 2026 | $868 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier CBGGKKVNJBK9, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Oct 21, 2026.